Ischemic and Bleeding Events of Ticagrelor Monotherapy in Korean Patients With and Without Diabetes Mellitus: Insights From the TICO Trial

Background: Ticagrelor monotherapy after 3 months dual antiplatelet therapy (DAPT) with aspirin and ticagrelor can reduce bleeding without increasing ischemic events after percutaneous coronary intervention (PCI). However, the impact of this approach among the patient with diabetes remains unknown....

Descripción completa

Detalles Bibliográficos
Autores principales: Yun, Kyeong Ho, Cho, Jae Young, Lee, Seung Yul, Rhee, Sang Jae, Kim, Byeong Keuk, Hong, Myeong Ki, Jang, Yangsoo, Oh, Seok Kyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845141/
https://www.ncbi.nlm.nih.gov/pubmed/33519487
http://dx.doi.org/10.3389/fphar.2020.620906

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845141/
https://www.ncbi.nlm.nih.gov/pubmed/33519487
http://dx.doi.org/10.3389/fphar.2020.620906

Ejemplares similares